UBS’s RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS DRGS Stock Holding History

UBS’s Portfolio DRGS Stock Details DRGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$74K	Buy	+1,460	New	+$72.1K	﹤0.01%	6370
2014 Q2	–	Sell	-41	Closed	-$2K	–	11229
2014 Q1	$2K	Sell	41 -207	-83%	-$9.33K	﹤0.01%	10133
2013 Q4	$10K	Buy	+248	New	+$9.73K	﹤0.01%	9045
2013 Q3	–	Sell	-784	Closed	-$26K	–	11066
2013 Q2	$26K	Buy	+784	New	+$26.8K	﹤0.01%	7591

Other funds holding DRGS

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS's DRGS Position: Q3 2014 in Review

UBS opened a new position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) in Q3 2014: 1,460 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #6370 among its holdings. This is a return to the name: UBS previously reported a position in DRGS as recently as Q1 2014.

UBS first reported a position in DRGS in Q2 2013 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold DRGS as of Q3 2014.

UBS held 1,460 shares of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS worth $74K as of Q3 2014.
RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS was a new UBS position in Q3 2014.
RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6370 holding.
UBS first reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in Q2 2013 and has held it in 4 quarters since.
4 funds tracked by Wall St. Rank held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.